Invited Article: Lost in a jungle of evidence
Open Access
- 11 November 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 71 (20) , 1634-1638
- https://doi.org/10.1212/01.wnl.0000336533.19610.1b
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]Neurology, 2008
- Rating the strength of scientific evidence: relevance for quality improvement programsInternational Journal for Quality in Health Care, 2004
- A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic StrokeNew England Journal of Medicine, 2001
- Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific IssuesAnnals of Internal Medicine, 2000
- Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) [RETIRED]Neurology, 2000
- Botulinum Toxin Type A as a Migraine Preventive TreatmentHeadache: The Journal of Head and Face Pain, 2000
- The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trialsBMJ, 1998
- Subverting Randomization in Controlled TrialsJAMA, 1995
- The Warfarin-Aspirin Symptomatic Intracranial Disease StudyNeurology, 1995
- Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic StrokeNew England Journal of Medicine, 1985